Skip to main content
Log in

Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer

  • Original Articles
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Asthenia is a very common symptom of patients with advanced cancer, but its investigation is hindered by a lack of suitable validated measuring instruments. The goal of the present study was to construct and validate a questionnaire for the study of asthenia in cancer patients, as well as to establish correlations with other symptoms and physiological and biochemical parameters. A group of 31 patients with advanced cancer and a control group of 30 healthy volunteers were examined. The proposed questionnaire, based on visual analogue scales, questions with categorical anwers and on the hospital anxiety and depression scale was validated by comparing results of the patient and control groups, by the test/retest method and by comparison with the evaluation of an observer. Correlation with various physiological and biochemical parameters was performed. The questionnaire distinguished well among the patients and control groups. VAS of asthenia proved quite stable over a period of 5 days. Correlations of asthenia with lack of appetite, the hospital anxienty and depression scale, weight, heart rate and serum cortisol levels could be established. No significant correlation between asthenia and various serum markers of inflammation and cytokines, including C-reactive protein, tumour necrosis factor, interleukin-1, and interleukin-2 receptors, could be found. The proposed questionnaire for evaluation of asthenia could be validated in a patient sample of limited size and a simplified questionnaire based on visual analogue scales is being developed for further investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams F, Quesada JR, Gutterman JU (1984) Neuropsychiatric manifestations of human leucocyte interferon therapy in patients with cancer. JAMA 252:938–941

    Google Scholar 

  2. Aylard PR, Gooding JH, McKenna PJ, Snaith RP (1987) A validation study of the anxiety and depression self-assessment scales. J Psychosom Res 31:261–268

    Google Scholar 

  3. Beutler B, Cerami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316:379–385

    Google Scholar 

  4. Bruera E, MacDonald RN (1988) Asthenia in patients with advanced cancer. J Pain Symptom Manage 3:9–14

    Google Scholar 

  5. Bruera E, Brenneis C, Michaud M, et al (1989) Association between asthenia and nutritional status, lean body mass, anemia, psychological status and tumor mass in patients with advanced breast cancer. J Pain Symptom Manage 4:59–63

    Google Scholar 

  6. Foa R, Guarini A, Francia de Celle P, Trentin L, Gillio Tos A, et al (1992) Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenias and effect of treatment with interferonalpha. J Clin Oncol 10:954–959

    Google Scholar 

  7. Herrmann C, Scholz KH, Kreuzer H (1991) Psychologisches Screening von Patienten einer kardiologischen Akutklinik mit einer deutschen Fassung der “Hospital Anxiety und Depression” (HAD) Skala. Psychother Psychosom Med Psychol 41:83–92

    Google Scholar 

  8. Holroyde CP, Axelrod RS, Skutches CL, et al (1979) Lactate metabolism in patients with metastatic colorectal cancer. Cancer Res 39:4900–4904

    Google Scholar 

  9. Lindemann A, Ludwig WD, Oster E, et al (1989) High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy-cell leukemia. Blood 73:880–883

    Google Scholar 

  10. Moldawer LL, Drott C, Lundholm K (1988) Monocytic production and plasma bioactivity of interleukin-1 and tumour necrosis factor in human cancer. Eur J Clin Invest 18:486–492

    Google Scholar 

  11. Morant R (1991) Asthenia, a double-edged defense against tumors. J Palliative Care 7:22–24

    Google Scholar 

  12. Ochoa JB, Curti B, Peitzman AB, Simmons RL, Billiar TR, et al (1992) Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with hemodynamic changes. J NCI 84:864–867

    Google Scholar 

  13. Rohatiner AZS, Prior PF, Burton AC, et al (1983) Central nervous systemic toxicity of interferon. Br J Cancer 47:418–422

    Google Scholar 

  14. Saunders C (1989) The management of terminal malignant disease, 2nd edn. Arnold, London Melbourne Auckland

    Google Scholar 

  15. Simonson E (1971) Physiology of work capacity and fatigue. Thomas, Springfield, III, pp 5–6

    Google Scholar 

  16. Stiefel F, Breitbart W, Kornblith A, Holland J (1990) Psychiatric distrurbances in cancer patients receiving high dose corticosteroids (poster abstract). 2nd International Symposium of Supportive Care in Cancer, St Gallen 1990

  17. Stiefel F, Morant R, Senn HJ (1992) Asthenie bei Tumorkranken-eine Übersicht. Dtsch Med Wochenschr 117:107–111

    Google Scholar 

  18. Theologides A (1986) Anorexins, asthenins, and cachectins in cancer. Am J Med 81:696–698

    Google Scholar 

  19. Tracey KJ, Wei H, Manogue KR, et al (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167:1211–1227

    Google Scholar 

  20. Waterhouse C (1974) Lactate metabolism in patients with cancer. Cancer 33:66–71

    Google Scholar 

  21. WHO (1990) Cancer pain relief and palliative care. WHO Tech Rep Ser 804:41

    Google Scholar 

  22. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 7:61–370

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morant, R., Stiefel, F., Berchtold, W. et al. Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer. Support Care Cancer 1, 101–107 (1993). https://doi.org/10.1007/BF00366904

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00366904

Key words

Navigation